Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket

Published 25/10/2022, 11:39
Updated 25/10/2022, 12:40
© Reuters.  Why Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket

Gainers

  • Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose 43% to $2.16 in pre-market trading. Astellas Pharma Inc. announced plans to invest a total of $50 million to acquire 15% of Taysha Gene Therapies.
  • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) shares rose 25.5% to $0.1470 in pre-market trading after declining 6% on Monday.
  • PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) rose 25.5% to $0.1769 in pre-market trading. PhaseBio plans for near-term sale using structured process through Chapter 11 of US Bankruptcy Code.
  • Weber Inc. (NYSE: WEBR) shares rose 22.1% to $6.14 in pre-market trading after BDT Capital Partners in amended 13D filing on Monday, offered to acquire all outstanding shares for $6.25 per share in cash.
  • RLX Technology Inc. (NYSE: RLX) rose 18% to $1.18 in pre-market trading. RLX Technology, last month, reported a second-quarter FY22 sales decline of 12% year-on-year to $333.50 million.
  • Mullen Automotive, Inc. (NASDAQ: MULN) rose 17.5% to $0.5876 in pre-market trading. The company said that the I-GO™, a new urban commercial electric delivery vehicle, is available now for select European markets. Mullen Automotive shares jumped 33% on Monday after the company secured exclusive sales, distribution, and branding rights to the new compact urban delivery electric vehicle, the I-GO, in select European markets.
  • First Wave BioPharma, Inc. (NASDAQ: FWBI) rose 12.1% to $1.39 in pre-market trading.
  • CN Energy Group. Inc. (NASDAQ: CNEY) shares rose 11.5% to $2.11 in pre-market trading.
  • Qualtrics International Inc. (NASDAQ: XM) rose 11.5% to $11.70 in pre-market trading after the company announced better-than-expected financial results and issued strong forecast.
  • Helbiz, Inc. (NASDAQ: HLBZ) rose 10.5% to $0.3424 in pre-market trading after gaining around 13% on Tuesday.
  • Virax Biolabs Group Limited (NASDAQ: VRAX) shares rose 8.8% to $1.48 in pre-market trading after dropping 4% on Monday.
  • Canopy Growth Corporation (NASDAQ: CGC) rose 7.9% to $2.47 in pre-market trading after declining over 4% on Monday.
  • View, Inc. (NASDAQ: VIEW) rose 7.7% to $1.12 in pre-market trading.
  • Weibo Corporation (NASDAQ: WB) rose 5.9% to $11.34 in pre-market trading after dropping over 12% on Monday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Don’t forget to check out our premarket coverage here .

Losers

  • Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares fell 20.4% to $0.2599 in pre-market trading after the company announced a 1-for-25 reverse stock split.
  • Statera Biopharma, Inc. (NASDAQ: STAB) fell 10.4% to $0.1125 in pre-market trading after dipping around 24% on Monday.
  • Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares fell 9.1% to $30.00 in pre-market trading after dropping 44% on Monday.
  • NextPlay Technologies, Inc. (NASDAQ: NXTP) fell 7.6% to $0.2411 in pre-market trading. NextPlay Technologies recently announced its NextFintech division received commitment for a $15 million strategic investment.
  • HSBC Holdings (LON:HSBA) plc (NYSE: HSBC) fell 7% to $25.06 in pre-market trading after the company posted a 42% decline in Q3 profit and named Georges Elhedery as its new chief financial officer.
  • Kaspien Holdings Inc. (NASDAQ: KSPN) fell 6.9% to $1.08 in pre-market trading after gaining around 5% on Monday.
  • Team, Inc. (NYSE: TISI) fell 6.9% to $0.75 in pre-market trading.
  • Zions Bancorporation (NASDAQ:ZION), National Association (NASDAQ: ZION) shares fell 4.9% to $47.35 in pre-market trading following downbeat Q3 earnings.
  • General Electric Company (NYSE: NYSE:GE) shares fell 3.2% to $70.98 in pre-market trading after reporting weak quarterly results.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.